Nextage Therapeutics (XTAE:NXTG) Dividends per Share: ₪0.00 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:NXTG Nextage Therapeutics Ltd XTAE:NXTG
12 GF Score
Price ₪0.44
GF Value ₪0.24
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Nextage Therapeutics Dividends per Share?

Nextage Therapeutics XTAE:NXTG 12 Dividends per Share is ₪0.00 as of Jun. 2026. GuruFocus rates XTAE:NXTG with a GF Score™ of 12/100 and a GF Value™ of ₪0.24 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Nextage Therapeutics's dividends per share for the six months ended in Jun. 2026 was ₪0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2026 was ₪0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2026 was 0.00. As of today, Nextage Therapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Nextage Therapeutics  (XTAE:NXTG) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Nextage Therapeutics's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=0/ -0.1
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nextage Therapeutics Dividends per Share Related Terms

Nextage Therapeutics Dividends per Share Historical Data

* Premium members only.

The historical data trend for Nextage Therapeutics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nextage Therapeutics Dividends per Share Chart

Nextage Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nextage Therapeutics Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XTAE:NXTG vs ZTS, UTHR, VTRS: Dividends per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nextage Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nextage Therapeutics Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nextage Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Nextage Therapeutics's Dividend Yield % falls into.


XTAE:NXTG
12GF Score
Nextage Therapeutics Ltd XTAE:NXTG
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nextage Therapeutics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of ₪0.00 mean?
Nextage Therapeutics (XTAE:NXTG) has a Dividends per Share of ₪0.00 as of Jun. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Nextage Therapeutics and its competitors.
Is Nextage Therapeutics' Dividends per Share too high?
Nextage Therapeutics' current Dividends per Share is ₪0.00. Overall, Nextage Therapeutics has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nextage Therapeutics' Dividends per Share compare to ZTS and UTHR?
Nextage Therapeutics' Dividends per Share of ₪0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Nextage Therapeutics and its competitors. Nextage Therapeutics's current Dividends per Share is ₪0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nextage Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Nextage Therapeutics (XTAE:NXTG) is currently considered Significantly Overvalued. The stock's GF Value™ is ₪0.24, compared to a current price of ₪0.44 — trading 83.3% above its estimated fair value. The current Dividends per Share is ₪0.00. Nextage Therapeutics' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Nextage Therapeutics (XTAE:NXTG), the current Dividends per Share is ₪0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nextage Therapeutics (XTAE:NXTG) Overvalued in 2026?

Based on GuruFocus' analysis, Nextage Therapeutics stock appears to be overvalued. The current stock price of ₪0.44 is trading 83.3% above its estimated GF Value™ of ₪0.24. GuruFocus considers Nextage Therapeutics to be Significantly Overvalued.

Key valuation signals for XTAE:NXTG:

  • Dividends per Share: ₪0.00
  • GF Value™: ₪0.24 vs. price of ₪0.44 (83.3% above fair value)
  • GF Score™: 12/100 with 4 warning signs

No single metric tells the full story. See the XTAE:NXTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nextage Therapeutics Business Description

Address Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581
Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.
12GF Score

Get the complete analysis for XTAE:NXTG

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.44
Price
₪0.24
GF Value